Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)

Revenue by Segment

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceuticals		22.78M	13.31M	18.20M	45.42M	69.76M
Pharmaceuticals Growth		71.17%	-26.88%	-59.93%	-34.89%	3.60%
Total		22.78M	13.31M	18.20M	45.42M	69.76M
Total Growth		71.17%	-26.88%	-59.93%	-34.89%	3.60%

Revenue by Geography

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Egypt		22.78M	13.31M	18.20M	45.42M	69.76M
Egypt Growth		71.17%	-26.88%	-59.93%	-34.89%	3.60%
Total		22.78M	13.31M	18.20M	45.42M	69.76M
Total Growth		71.17%	-26.88%	-59.93%	-34.89%	3.60%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 21, 2026

Data Sources Report a data error